Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2000
11/30/2000WO2000071156A2 New vaccine formulations-3
11/30/2000WO2000071155A2 New vaccine formulations - 2
11/30/2000WO2000071154A2 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071142A1 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/30/2000WO2000071077A2 Adjuvant which is optimized with regard to stability and biocompatibility (sba) and which is provided for increasing the humoral and cellular immune response
11/30/2000WO2000050607A3 Goodpasture antigen binding protein
11/30/2000WO2000044404A3 Methods for inhibiting brain tumor growth by using selected integrin antagonists
11/30/2000WO2000043790A3 Compositions and methods for the diagnosis and treatment of tumor
11/30/2000WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
11/30/2000WO2000043037A3 Hiv-encoded chemoattractant
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000040261A3 Vaccination method for efficient induction of cytotoxic t lymphocyte response
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000WO2000014119A3 Bifunctional antibodies and their use in targeting anti-tumour agents
11/30/2000DE19924199A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/30/2000CA2838395A1 Combination neisserial compositions
11/30/2000CA2375072A1 Prodrug activation using catalytic antibodies
11/30/2000CA2375032A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374520A1 Secreted alpha-helical protein - 32
11/30/2000CA2374364A1 Polypeptides and polynucleotides from moraxella catarrhalis
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2373992A1 Medicinal compositions containing anti-fas antibody
11/30/2000CA2373748A1 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues
11/30/2000CA2373285A1 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000CA2373239A1 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
11/30/2000CA2373236A1 Combination neisserial compositions
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/30/2000CA2371356A1 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/29/2000EP1055429A1 Novel preventives/remedies for immunopathy
11/29/2000EP1054980A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
11/29/2000EP1054979A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
11/29/2000EP1054973A1 Antigen library immunization
11/29/2000EP1054971A2 Group b streptococcus antigens
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054954A1 Development of regulatory cells as a means for treating autoimmune disease
11/29/2000EP1054953A1 NOVEL pgsA
11/29/2000EP1054950A2 Hiv chemokines
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054901A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
11/29/2000EP1054896A1 ANALGESIC PEPTIDES FROM VENOM OF $i(GRAMMOSTOLA SPATULATA) AND USE THEREOF
11/29/2000EP1054895A1 Novel peptide diagnostic reagent and kit for detection of rickettsiosis
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054691A1 Skin care compositions
11/29/2000EP1054690A2 Hapten-modified tumor cell membranes and their use
11/29/2000EP1054689A1 Strategically modified hepatitis b core proteins and their derivatives
11/29/2000EP1054688A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275164A Neisseria lactoferrin binding protein
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275161A Monoclonal antibody 3-6-A specific to surface of dendritic cells among the peripheral blood leukocytes
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275084A Recombinant porcine adenovirus vector
11/29/2000CN1274755A Human protein kinase inhibitor II and its code sequence, preparation process and application
11/29/2000CN1274607A Technological process of preparing rabies vaccine with hamster kidney cell
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153580 For generating an immune response in host
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153421 Nucleotide sequences which code microorganismal genome; for development of viricides; for preventing mammalian viral infection
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
11/28/2000US6153401 Microorganisms and plasmids for 2,4-dichlorophenoxyacetic acid (2,4-D) monooxygenase formation and process for the production of these plasmids and strains
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153377 Synthetic DNA derived recombinant HIV antigens
11/28/2000US6153203 Immunological tolerance-inducing agent
11/28/2000US6153202 In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153195 Method of delivering drugs to cells specific for an HL-60 lectin
11/28/2000US6153194 Borrelia burgdorferi outer membrane proteins
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000US6153191 Giardia treatment and antibody
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000US6153182 Lymphotactin as an adjuvant
11/28/2000US6153129 Production scale method of forming microparticles
11/28/2000CA2307357A1 Wbpp and method for assay of wbpp
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA2032253C 5-lipoxygenase activating protein
11/28/2000CA1341148C Methods and compositions for the preparation of treponema pallidum antigens, including purified antigens and dna sequences coding therefor
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
1 ... 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 ... 1823